N. Farahani, Moein Enayati, Andredi Pumarejo, Mateo Alzate Aguirre, Christopher G. Scott, Konstantinos C. Siontis, Martijn Bos, J. Geske, M. Ackerman, Adelaide M. Arruda-Olson
{"title":"肥厚性心肌病患者心律失常猝死生存预测模型:可解释的机器学习分析","authors":"N. Farahani, Moein Enayati, Andredi Pumarejo, Mateo Alzate Aguirre, Christopher G. Scott, Konstantinos C. Siontis, Martijn Bos, J. Geske, M. Ackerman, Adelaide M. Arruda-Olson","doi":"10.1115/dmd2023-2989","DOIUrl":null,"url":null,"abstract":"\n Hypertrophic Cardiomyopathy (HCM) is an inheritable heart disease with the highest rate of sudden cardiac death (SCD) in young adults. Implantable Cardioverter Defibrillator (ICD) therapy is recommended for HCM patients at high risk for SCD. Reviewing the recent clinical literature revealed the potential to improve the selection of candidates for ICD implantation. The current study uses information extracted from echocardiography reports to evaluate HCM patients with ICD and aims to provide a comparative insight into patients who benefited the most from the device therapy, including shock and anti-tachycardia pacing (ATP). The proposed interpretable machine learning approach has used the XGboost algorithm. The model’s performance was considered satisfactory, as evidenced by an accuracy score of 81% and an area under the receiver operating characteristic curve (AUC) value of 69% and SHapley Additive exPlanations (SHAP) identified common properties of HCM patients in each category and provided high-level reasoning and foundation for a clinical decision support tool.","PeriodicalId":325836,"journal":{"name":"2023 Design of Medical Devices Conference","volume":"17 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"ARRHYTHMIC SUDDEN DEATH SURVIVAL PREDICTION MODEL FOR HYPERTROPHIC CARDIOMYOPATHY PATIENTS: AN INTERPRETABLE MACHINE LEARNING ANALYSIS\",\"authors\":\"N. Farahani, Moein Enayati, Andredi Pumarejo, Mateo Alzate Aguirre, Christopher G. Scott, Konstantinos C. Siontis, Martijn Bos, J. Geske, M. Ackerman, Adelaide M. Arruda-Olson\",\"doi\":\"10.1115/dmd2023-2989\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n Hypertrophic Cardiomyopathy (HCM) is an inheritable heart disease with the highest rate of sudden cardiac death (SCD) in young adults. Implantable Cardioverter Defibrillator (ICD) therapy is recommended for HCM patients at high risk for SCD. Reviewing the recent clinical literature revealed the potential to improve the selection of candidates for ICD implantation. The current study uses information extracted from echocardiography reports to evaluate HCM patients with ICD and aims to provide a comparative insight into patients who benefited the most from the device therapy, including shock and anti-tachycardia pacing (ATP). The proposed interpretable machine learning approach has used the XGboost algorithm. The model’s performance was considered satisfactory, as evidenced by an accuracy score of 81% and an area under the receiver operating characteristic curve (AUC) value of 69% and SHapley Additive exPlanations (SHAP) identified common properties of HCM patients in each category and provided high-level reasoning and foundation for a clinical decision support tool.\",\"PeriodicalId\":325836,\"journal\":{\"name\":\"2023 Design of Medical Devices Conference\",\"volume\":\"17 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-04-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"2023 Design of Medical Devices Conference\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1115/dmd2023-2989\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"2023 Design of Medical Devices Conference","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1115/dmd2023-2989","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
ARRHYTHMIC SUDDEN DEATH SURVIVAL PREDICTION MODEL FOR HYPERTROPHIC CARDIOMYOPATHY PATIENTS: AN INTERPRETABLE MACHINE LEARNING ANALYSIS
Hypertrophic Cardiomyopathy (HCM) is an inheritable heart disease with the highest rate of sudden cardiac death (SCD) in young adults. Implantable Cardioverter Defibrillator (ICD) therapy is recommended for HCM patients at high risk for SCD. Reviewing the recent clinical literature revealed the potential to improve the selection of candidates for ICD implantation. The current study uses information extracted from echocardiography reports to evaluate HCM patients with ICD and aims to provide a comparative insight into patients who benefited the most from the device therapy, including shock and anti-tachycardia pacing (ATP). The proposed interpretable machine learning approach has used the XGboost algorithm. The model’s performance was considered satisfactory, as evidenced by an accuracy score of 81% and an area under the receiver operating characteristic curve (AUC) value of 69% and SHapley Additive exPlanations (SHAP) identified common properties of HCM patients in each category and provided high-level reasoning and foundation for a clinical decision support tool.